Skip to main content

Rabbit Polyclonal POLR1A antibody. Suitable for ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human POLR1A aa 800-950.

Be the first to review this product! Submit a review

Images

Immunocytochemistry/ Immunofluorescence - Anti-POLR1A antibody (AB222065), expandable thumbnail

Publications

Key facts

Isotype
IgG
Host species
Rabbit
Storage buffer

pH: 7.2
Preservative: 0.02% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine)

Form
Liquid
Clonality
Polyclonal

Immunogen

  • Recombinant Fragment Protein within Human POLR1A aa 800-950. The exact immunogen used to generate this antibody is proprietary information. Database link O95602

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
ICC/IF
Human
Tested
Mouse
Predicted
Rat
Predicted

Tested
Tested

Species
Human
Dilution info
0.25000-2.00000 µg/mL
Notes

Fixation/Permeabilization: PFA/Triton X-100.

Predicted
Predicted

Species
Mouse, Rat
Dilution info
-
Notes

-

Associated Products

Select an associated product type

2 products for Alternative Product

Target data

Function

Catalytic core component of RNA polymerase I (Pol I), a DNA-dependent RNA polymerase which synthesizes ribosomal RNA precursors using the four ribonucleoside triphosphates as substrates. Transcribes 47S pre-rRNAs from multicopy rRNA gene clusters, giving rise to 5.8S, 18S and 28S ribosomal RNAs (PubMed:11250903, PubMed:11283244, PubMed:16858408, PubMed:34671025, PubMed:34887565, PubMed:36271492). Pol I-mediated transcription cycle proceeds through transcription initiation, transcription elongation and transcription termination stages. During transcription initiation, Pol I pre-initiation complex (PIC) is recruited by the selectivity factor 1 (SL1/TIF-IB) complex bound to the core promoter that precedes an rDNA repeat unit. The PIC assembly bends the promoter favoring the formation of the transcription bubble and promoter escape. Once the polymerase has escaped from the promoter it enters the elongation phase during which RNA is actively polymerized, based on complementarity with the template DNA strand. Highly processive, assembles in structures referred to as 'Miller trees' where many elongating Pol I complexes queue and transcribe the same rDNA coding regions. At terminator sequences downstream of the rDNA gene, PTRF interacts with Pol I and halts Pol I transcription leading to the release of the RNA transcript and polymerase from the DNA (PubMed:11250903, PubMed:11283244, PubMed:16858408, PubMed:34671025, PubMed:34887565, PubMed:36271492). Forms Pol I active center together with the second largest subunit POLR1B/RPA2. Appends one nucleotide at a time to the 3' end of the nascent RNA, with POLR1A/RPA1 contributing a Mg(2+)-coordinating DxDGD motif, and POLR1B/RPA2 participating in the coordination of a second Mg(2+) ion and providing lysine residues believed to facilitate Watson-Crick base pairing between the incoming nucleotide and the template base. Typically, Mg(2+) ions direct a 5' nucleoside triphosphate to form a phosphodiester bond with the 3' hydroxyl of the preceding nucleotide of the nascent RNA, with the elimination of pyrophosphate. Has proofreading activity: Pauses and backtracks to allow the cleavage of a missincorporated nucleotide via POLR1H/RPA12. High Pol I processivity is associated with decreased transcription fidelity (By similarity) (PubMed:11250903, PubMed:11283244, PubMed:16858408, PubMed:34671025, PubMed:34887565, PubMed:36271492).

Alternative names

Recommended products

Rabbit Polyclonal POLR1A antibody. Suitable for ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human POLR1A aa 800-950.

Key facts

Isotype
IgG
Form
Liquid
Clonality
Polyclonal
Immunogen
  • Recombinant Fragment Protein within Human POLR1A aa 800-950. The exact immunogen used to generate this antibody is proprietary information. Database link O95602
Purification technique
Affinity purification Immunogen
Concentration
Loading...

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

The POLR1A protein also known as RNA polymerase I subunit RPA1 plays an important mechanical role in the synthesis of ribosomal RNA (rRNA). POLR1A has a molecular mass of approximately 194 kDa. This protein is ubiquitously expressed across various tissues contributing extensively to the cellular machinery for protein synthesis. As an essential component of RNA polymerase I POLR1A shares structural features typical of RNA polymerase enzymes facilitating the transcription of rRNA genes.

Biological function summary

POLR1A functions as part of the RNA polymerase I complex which specializes in transcribing rRNA a critical component of ribosome biogenesis. This process is central to the synthesis of rRNA precursors which later modify to form mature rRNA. POLR1A works in conjunction with other subunits to ensure efficient and accurate transcription within the nucleolus demonstrating its significance in maintaining cellular protein synthesis capacity. The protein's activity supports the assembly of ribosomes influencing cell growth and division.

Pathways

POLR1A is integrally involved in the ribosome biogenesis and rRNA transcription pathways. These pathways are essential for producing ribosomes the molecular machines responsible for protein translation in cells. POLR1A has interactions with proteins like TIF-IA and UBF both of which regulate its transcriptional activity at specific rRNA gene promoters. This interaction regulates POLR1A's function in response to cellular conditions ensuring that protein synthesis matches cellular demands.

Associated diseases and disorders

POLR1A's function has links to conditions like Treacher Collins syndrome and Acrofacial Dysostosis. Mutations in POLR1A can lead to defects in ribosome biogenesis disrupting the growth and development of craniofacial structures observed in these syndromes. Additionally POLR1A interacts with proteins such as NOP56 and fibrillarin which are involved in rRNA processing and assembly suggesting that any disruptions in these interactions could contribute to ribosomopathies. POLR1A's role in maintaining rRNA transcription highlights its significance in preventing defects that translate to broader systemic issues.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

1 product image

  • Immunocytochemistry/ Immunofluorescence - Anti-POLR1A antibody (ab222065), expandable thumbnail

    Immunocytochemistry/ Immunofluorescence - Anti-POLR1A antibody (ab222065)

    PFA-fixed, Triton X-100 permeabilized U-2 OS (human bone osteosarcoma epithelial cell line) cells stained for POLR1A (green) using ab222065 at 4 μg/ml in ICC/IF.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com